BIEL APPEAL AS A REVERSE MERGER BIEL has advant
Post# of 8470

BIEL has advantages that could make it more attractive than average as a reverse merger candidate, such as:
Low Share Price & High Volume: BIEL trades at fractions of a cent, which makes it easy for a private company to acquire a controlling stake without spending much.
Established Ticker & OTC Listing: It’s already publicly traded, which simplifies the process for a private company to go public via merger.
Specialized IP: BIEL owns FDA-cleared medical devices like ActiPatch and RecoveryRx, which could be valuable assets or a platform for expansion.
Minimal Operations: With only a handful of employees and limited revenue, it may be easier to pivot the business post-merger.
Compared to Other Penny Stocks
Many OTC stocks are either dormant shells or failed ventures with no real assets. BIEL at least has real products, regulatory approvals, and some revenue—so it’s arguably more viable than a pure shell.

